Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Should we reevaluate antibiotic breakpoints?

M J Ferraro1

  • 1Clinical Microbiology Laboratory, Massachusetts General Hospital, Boston, MA 02114, USA. mferraro@partners.org

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes.

Journal of clinical microbiology·2015
Same author

Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
Same author

Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
Same author

Primary neuroendocrine lung tumor presenting with acute ileal obstruction. Case report.

Il Giornale di chirurgia·2013
Same author

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

Infection control and hospital epidemiology·2010
Same author

High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora.

Antimicrobial agents and chemotherapy·2005
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Antimicrobial susceptibility test breakpoints require careful initial determination and periodic reevaluation. Global coordination of testing methods and breakpoint setting is essential for accurate antibiotic resistance monitoring.

Area of Science:

  • Clinical microbiology
  • Pharmacology
  • Infectious diseases

Background:

  • Accurate interpretation of antimicrobial susceptibility tests (AST) relies on established breakpoints.
  • Breakpoints guide antibiotic selection for treating bacterial infections.
  • Changes in bacterial resistance, testing methods, and antibiotic formulations necessitate breakpoint updates.

Purpose of the Study:

  • To emphasize the critical need for rigorous initial determination and ongoing reevaluation of antimicrobial susceptibility test breakpoints.
  • To highlight the roles of various agencies in establishing and updating breakpoints.
  • To advocate for global harmonization of AST methods and breakpoint setting.

Main Methods:

  • Review of factors influencing breakpoint establishment (microbiological, pharmacokinetic, pharmacodynamic, clinical data).

Related Experiment Videos

  • Examination of the process for breakpoint reevaluation.
  • Discussion of international and national bodies responsible for breakpoint setting.

    • Main Results:

    • Breakpoints must be based on a comprehensive data set and regularly updated.
    • National organizations, such as the National Committee for Clinical Laboratory Standards in the US, have established review mechanisms.
    • Discrepancies exist in breakpoint setting globally.

    Conclusions:

    • Continuous monitoring and updating of antimicrobial susceptibility breakpoints are crucial for effective antimicrobial stewardship.
    • International collaboration is needed to standardize susceptibility testing methods and breakpoint criteria worldwide.
    • Harmonized breakpoints will improve global surveillance of antibiotic resistance and optimize patient treatment outcomes.